Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans.
about
Role of CD1d-restricted NKT cells in microbial immunityThe Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8(+) T Cell GenerationHost immunity to Cryptococcus neoformansA glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primatesGlycolipids that Elicit IFN-γ-Biased Responses from Natural Killer T CellsT cell-mediated host immune defenses in the lungNatural killer T cells activated by a lipopeptidophosphoglycan from Entamoeba histolytica are critically important to control amebic liver abscessEnhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.The stimulating adventure of KRN 7000.Alpha-galactosylceramide promotes killing of Listeria monocytogenes within the macrophage phagosome through invariant NKT-cell activationDuring Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface proteinAlpha-galactosylceramide as a therapeutic agent for pulmonary Mycobacterium tuberculosis infection.Activation of NKT cells protects mice from tuberculosis.CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infectionGlycolipid targets of CD1-mediated T-cell responses.Peripheral blood invariant natural killer T cells of pig-tailed macaquesCross-talk between cd1d-restricted nkt cells and γδ cells in t regulatory cell response.Understanding the function of CD1-restricted T cells.Major histocompatibility complex-dependent susceptibility to Cryptococcus neoformans in miceMouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivoRole of granulocyte macrophage colony-stimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis.Genetic control of NKT cell numbers.CD1d-restricted T-cell subsets and dendritic cell function in autoimmunity.IL-23 dampens the allergic response to Cryptococcus neoformans through IL-17-independent and -dependent mechanisms.Cyclic di-GMP stimulates protective innate immunity in bacterial pneumoniaNatural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines.Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer stainingConnecting the dots: artificial antigen presenting cell-mediated modulation of natural killer T cells.Boosting the Immune Response: The Use of iNKT cell ligands as vaccine adjuvantsc-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection.Carbohydrates and T cells: a sweet twosome.beta-Glycosphingolipids as immune modulators.Intracellular bacterial infection and invariant NKT cells.Glucocerebroside: an evolutionary advantage for patients with Gaucher disease and a new immunomodulatory agent.Age-related resistance of C57BL/6 mice to Cryptococcus neoformans is dependent on maturation of NKT cells.Exacerbation of invasive Candida albicans infection by commensal bacteria or a glycolipid through IFN-γ produced in part by iNKT cells.Interleukin-17A enhances host defense against cryptococcal lung infection through effects mediated by leukocyte recruitment, activation, and gamma interferon productionAutoreactive natural killer T cells: promoting immune protection and immune tolerance through varied interactions with myeloid antigen-presenting cells.Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens.Clinical development of a novel CD1d-binding NKT cell ligand as a vaccine adjuvant.
P2860
Q24294851-D8C03DDB-E29F-48EE-B7B3-1882FD23D265Q26797344-F31245A0-4A03-4A4F-9A66-7BB4695E601EQ26823438-C75D169A-29B7-4CCB-B838-06EAEB31C83CQ27303293-C06306AA-ED99-4D84-8950-DFA430543DEDQ27676395-53230444-9335-4B09-B079-0EF274590F06Q28395374-95016C4D-D59F-4474-8FB8-4A55162BDA3BQ33444653-78B9796F-02A0-488D-BCE5-A97FF957DB46Q33552034-30203FF8-C195-49CE-A8FF-1D111D2F667FQ33843406-D0712C6C-37A8-4EE4-AE71-0092CDE4B98BQ33877217-F1253CC1-B5A1-446F-87AA-C6D8B620F1C8Q34115997-9F6E243D-8F92-4D12-B6B6-E1B8A52A1277Q34172161-8F436F43-A872-40C8-88A6-4BCCF358C3B4Q34182581-23972E07-27BD-4C2E-BE05-01A5E623C8C6Q34402230-672E2F2C-6E45-424D-BEBC-CE0B5DE9CFD1Q34448496-CF453E5E-6C74-47AF-B38A-259C2EBEB3E4Q34461021-7EDB7F5B-9988-49FF-9DD0-971F7FD24F00Q34550454-7ECD5188-9DE9-4846-8AFE-CA1926F9568FQ35139857-27CE8782-5D89-4142-B019-DD719E10BA8CQ35165078-DB9F5F8B-C673-43FA-9906-A5E930CD9295Q35168204-982954BA-8283-4A3F-9F0D-146E2E85F2D3Q35781421-55220F48-5FEB-497B-BBF2-22D4D96C54E5Q35798141-6CE8636F-2D5E-4DBC-A53B-1E08637D00A7Q35798159-9C5E5CBB-7886-4329-8073-E7B1641BCDC8Q35952109-D8530911-28ED-4F11-9E4A-6D3B443FB47AQ36097274-0B34611F-9774-40E9-8C2B-2502671628BFQ36370322-C0881C60-185B-44B7-983F-E34188FAF136Q36370359-981F70BB-431D-414C-B41B-79A755DF808CQ36383130-2164C3DD-28E0-45D2-A255-A6793DCE782CQ36474450-EC43E98E-B677-4F73-A1B4-41A3E6E6E7A6Q37109444-F5BA767A-9184-4BC8-83DD-5AAF159A8702Q37118132-6964859C-CEAB-4B54-B027-0AACA3CE12C3Q37196707-E96A385E-2033-45AD-A690-2A328B666FBDQ37405955-F34073D4-C1BA-4F1C-9392-81C47F816BA8Q37520646-3EF92DE5-F891-4E1E-A034-42F16E54E196Q37521737-571AB25A-33C7-451B-93C6-C49BEDA83B31Q37582319-1A7B746A-D756-4955-AC31-3EEBAF5E9B87Q37643828-8A4BC9A8-BFAC-43F0-9E7C-7E9F401C4B26Q37750917-F77165BE-9CA5-46B3-B2DA-FAD53DAAAA03Q37822744-FFBD0AFE-E902-412F-9E48-4D9D5EEB49FEQ37824065-C2E34105-6C20-40A4-8EEC-7A6B9E8A92B3
P2860
Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Activation of Valpha14
@nl
Activation of Valpha14(+) natu ...... with Cryptococcus neoformans.
@en
type
label
Activation of Valpha14
@nl
Activation of Valpha14(+) natu ...... with Cryptococcus neoformans.
@en
prefLabel
Activation of Valpha14
@nl
Activation of Valpha14(+) natu ...... with Cryptococcus neoformans.
@en
P2093
P2860
P1476
Activation of Valpha14(+) natu ...... with Cryptococcus neoformans.
@en
P2093
K Kawakami
M Taniguchi
P2860
P304
P356
10.1128/IAI.69.1.213-220.2001
P407
P577
2001-01-01T00:00:00Z